NO881111L - Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev. - Google Patents

Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev.

Info

Publication number
NO881111L
NO881111L NO88881111A NO881111A NO881111L NO 881111 L NO881111 L NO 881111L NO 88881111 A NO88881111 A NO 88881111A NO 881111 A NO881111 A NO 881111A NO 881111 L NO881111 L NO 881111L
Authority
NO
Norway
Prior art keywords
human
animal tissues
isolating
procedure
membrane proteins
Prior art date
Application number
NO88881111A
Other languages
English (en)
Other versions
NO173336B (no
NO173336C (no
NO881111D0 (no
Inventor
Dietrich Brocks
Rubert Timpl
Mats Paulsson
Original Assignee
Hoechst Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Max Planck Gesellschaft filed Critical Hoechst Ag
Publication of NO881111D0 publication Critical patent/NO881111D0/no
Publication of NO881111L publication Critical patent/NO881111L/no
Publication of NO173336B publication Critical patent/NO173336B/no
Publication of NO173336C publication Critical patent/NO173336C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00Gas and liquid contact apparatus
    • Y10S261/88Aroma dispensers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/82Subcellular parts of microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Tires In General (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO881111A 1987-03-13 1988-03-11 Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein NO173336C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873708198 DE3708198A1 (de) 1987-03-13 1987-03-13 Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben

Publications (4)

Publication Number Publication Date
NO881111D0 NO881111D0 (no) 1988-03-11
NO881111L true NO881111L (no) 1988-09-14
NO173336B NO173336B (no) 1993-08-23
NO173336C NO173336C (no) 1993-12-01

Family

ID=6323001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881111A NO173336C (no) 1987-03-13 1988-03-11 Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein

Country Status (11)

Country Link
US (1) US5147782A (no)
EP (1) EP0282018B1 (no)
JP (1) JP2532559B2 (no)
AT (1) ATE124706T1 (no)
DE (2) DE3708198A1 (no)
DK (1) DK173677B1 (no)
ES (1) ES2074983T3 (no)
FI (1) FI99114C (no)
IE (1) IE67563B1 (no)
NO (1) NO173336C (no)
PT (1) PT86944B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541076A (en) * 1988-12-12 1996-07-30 Bard Diagnostic Sciences, Inc. Methods for determining the invasiveness of a bladder tumor
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
WO1992019970A1 (en) * 1991-04-26 1992-11-12 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
NZ524868A (en) 2003-03-21 2005-09-30 Velvet Antler Res New Zealand Process for purifying low molecular weight proteins from tissue in situ
NZ526157A (en) * 2003-05-27 2006-01-27 Velvet Antler Res New Zealand Method for the extraction of deer antler and use of the extract therefrom
US20070190165A1 (en) * 2005-10-21 2007-08-16 Brey Eric M Tissue-specific basement membrane gels
US10076535B2 (en) 2012-04-27 2018-09-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923583A1 (de) * 1979-06-11 1980-12-18 Max Planck Gesellschaft Verfahren zur immunologischen bestimmung von basalmembranmaterial und hierfuer geeignete neue basalmembranfragmente
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
DE3511199A1 (de) * 1985-03-28 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur immunologischen bestimmung von heparansulfat-proteoglykan, verfahren zur herstellung bzw. reinigung von dafuer geeignetem heparansulfat-proteoglykan aus basalmembran-haltigen geweben
JPH01155757A (ja) * 1987-12-11 1989-06-19 Nec Corp 可変不在転送解除方式

Also Published As

Publication number Publication date
FI881122A0 (fi) 1988-03-10
JP2532559B2 (ja) 1996-09-11
JPS63243098A (ja) 1988-10-07
FI881122A (fi) 1988-09-14
PT86944A (pt) 1988-04-01
FI99114B (fi) 1997-06-30
NO173336B (no) 1993-08-23
PT86944B (pt) 1992-05-29
DK135688A (da) 1988-09-14
DK135688D0 (da) 1988-03-11
FI99114C (fi) 1997-10-10
EP0282018A3 (en) 1990-01-24
IE67563B1 (en) 1996-04-17
IE880729L (en) 1988-09-13
US5147782A (en) 1992-09-15
EP0282018B1 (de) 1995-07-05
NO173336C (no) 1993-12-01
DE3854096D1 (de) 1995-08-10
EP0282018A2 (de) 1988-09-14
ES2074983T3 (es) 1995-10-01
ATE124706T1 (de) 1995-07-15
DE3708198A1 (de) 1988-09-22
NO881111D0 (no) 1988-03-11
DK173677B1 (da) 2001-06-11

Similar Documents

Publication Publication Date Title
EP0089666A3 (en) Human growth hormone variants
DK185180A (da) Denatureringsbestandige vandige proteinoploesninger og fremgangsmaade til fremstilling deraf
NO884135D0 (no) Vannopploeselig cellulosederivat, fremgangsmaate for dets fremstilling og anvendelse derav.
DE240975T1 (de) Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen.
NO833769L (no) Immunogent protein- eller peptidkompleks, fremgangsmaate for fremstilling og anvendelse herav som immunstimulerende middel og som vaksine
NL7800767A (nl) Additieverbinding van dipeptidederivaat en aminozuurderivaat evenals de werkwijze voor de bereiding hiervan.
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
DE3874019T2 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
AU524777B2 (en) Isolation of tissue protein ppg.
NO881111L (no) Fremgangsmaate til isolering av basalmembranproteiner fra menneskelige og dyriske vev.
SE8703064D0 (sv) Method for isolating active enzyme preparations from animal tissues
DE3478958D1 (en) Protein conjugates of penicilloic acid, their preparation and use
NO986218D0 (no) FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
FI883450A (fi) Menetelmä istukan kudosproteiinin PP4 puhdistamiseksi
DE3067643D1 (en) Protein pp 11, process for its isolation and its use
DE3882411T2 (de) Verfahren zur Trennung von aktiviertem menschlichem Protein C.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
DE3872790D1 (de) Geraet zur untersuchung von reissverschlusselementen.
NO161596C (no) Fremgangsmaate for gjenvinning av proteiner og andre naeringsstoffer fra proteinholdig vann.
ES492470A0 (es) Procedimiento de obtencion de una solucion de aminoacidos y peptidos de origen animal por proceso enzimatico
GB2229725B (en) A method of enhancing neutralising antibody activity in human or animal sera or in other body secreations
DE3784891T2 (de) Verfahren zur Isolierung von säurestabilen, biologisch aktiven Proteinen.
DK306479A (da) N-cyclohexyl-n-methoxyacetoacetamid, fremgangsmaade til fremstilling deraf og anvendelse deraf til fremstilling af o-methyl-n-cyclohexyl-2,5-dimethylfuran-3-hydroxamsyre
ES2076238T3 (es) Adnc que codifica la proteina 9 de placenta (pp9), su aislamiento y utilizacion.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003